favipiravir
Showing 1 - 25 of 46
Infectious Disease, Pharmacology Trial in Paris (favipiravir, Placebo)
Not yet recruiting
- Infectious Disease
- Pharmacology
- favipiravir
- Placebo
-
Paris, FranceUniversity Hospital Bichat - Claude Bernard
Aug 31, 2023
COVID-19 Trial in London (Favipiravir, Lopinavir/ Ritonavir, Favipiravir Placebo)
Completed
- COVID-19
- Favipiravir
- +3 more
-
London, United Kingdom
- +1 more
Dec 12, 2022
Sars-CoV2, COVID-19 Trial in Stanford (Favipiravir, Placebo, Standard of care treatment)
Completed
- Sars-CoV2
- COVID-19
- Favipiravir
- +2 more
-
Stanford, CaliforniaStanford University
Jul 6, 2022
SARS-CoV-2 Infection Trial in Hungary (Favipiravir)
Completed
- SARS-CoV-2 Infection
- Favipiravir
-
Budapest, Hungary
- +4 more
Oct 30, 2022
Moderate to Severe COVID-19 Trial in Shanghai, Tashkent (JT001, JT001 , Favipiravir)
Not yet recruiting
- Moderate to Severe COVID-19
- JT001
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Mar 14, 2022
COVID-19 Trial in United States (Favipiravir, Standard of Care)
Completed
- COVID-19
- Favipiravir
- Standard of Care
-
Scottsdale, Arizona
- +7 more
Mar 25, 2022
Covid19 Trial in George Town (Favipiravir)
Completed
- Covid19
- Favipiravir
-
George Town, Pulau Pinang, MalaysiaPenang General Hospital
Nov 15, 2021
COVID-19 Trial in Saudi Arabia (Favipiravir, Placebo)
Completed
- COVID-19
- Favipiravir
- Placebo
-
Al Madinah, Saudi Arabia
- +6 more
Nov 4, 2021
Covid19 Trial in Ciudad de Mexico (Favipiravir, Nitazoxanide, Nitazoxanide Placebo)
Recruiting
- Covid19
- Favipiravir
- +2 more
-
Ciudad de Mexico, Azcapotzalco, MexicoHospital de Infectología "Daniel Méndez Hernández" del Centro Mé
Oct 18, 2021
Infectious Disease, SARS-CoV Infection, Covid19 Trial in Magelang, Semarang, Jakarta (Favipiravir, Azithromycin)
Recruiting
- Infectious Disease
- +2 more
- Favipiravir
- Azithromycin
-
Magelang, Central Java, Indonesia
- +2 more
Oct 3, 2021
SARS-CoV 2, COVID-19 Trial in Manama (Hydroxychloroquine, Favipiravir, Routine care for COVID-19 patients)
Completed
- SARS-CoV 2
- COVID-19
- Hydroxychloroquine
- +2 more
-
Manama, BahrainRoyal College of Surgeons in Ireland - Bahrain
Oct 25, 2021
Coronavirus Infection Trial in Brazil, Mexico, United Kingdom (Favipiravir, Standard of care management)
Completed
- Coronavirus Infection
- Favipiravir
- Standard of care management
-
Porto Alegre, Brazil
- +5 more
Nov 17, 2021
COVID-19, SARS-CoV-2 Trial in Toronto (Favipiravir, Favipiravir Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- Favipiravir
- Favipiravir Placebo
-
Toronto, Ontario, CanadaMount Sinai Hospital
Aug 11, 2021
Antiviral Drugs on the Treatment of SARS-CoV-2
Recruiting
- Complication of Medical Care
- Pneumonia, Viral
- Favipiravir
- Remdesivir
-
Nur-Sultan, Kazakhstan
- +1 more
Jul 19, 2022
COVID Trial in Melbourne (Favipiravir)
Active, not recruiting
- COVID
- Favipiravir
-
Melbourne, Victoria, AustraliaAlfred Health
Oct 6, 2021
COVID Trial in Tanta (Favipiravir, Chloroquine)
Completed
- COVID
- Favipiravir
- Chloroquine
-
Tanta, EgyptTanta University, Ainshams University
Oct 29, 2021
SARS-CoV2, COVID-19 Trial in Ankara, Istanbul (Ribavirin Capsules, Favipiravir)
Not yet recruiting
- SARS-CoV2
- COVID-19
- Ribavirin Capsules
- Favipiravir
-
Ankara, Cebeci, Turkey
- +3 more
Apr 1, 2021
Favipiravir in Treatment of COVID-19 Patients Over 15 Years of
Active, not recruiting
- COVID-19
- Favipiravir
-
Ankara, TurkeyHacettepe University, School of Medicine
Jan 29, 2021
COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)
Completed
- COVID-19
- Casirivimab and Imdevimab Drug Combination
- +2 more
-
Mansoura, El-dkhalia, EgyptEl-gomhoria St
Aug 13, 2022
COVID-19 Respiratory Infection, FLU, Cold; Influenza Trial in Kayseri (Kunamin®, Favipiravir, Enoxaparin)
Completed
- COVID-19 Respiratory Infection
- +4 more
- Kunamin®
- +6 more
-
Kayseri, Kayseri Province, TurkeyKayseri City Hospital
Jun 10, 2022
Covid19 Trial in Kathmandu, Pokhara (Favipiravir, Placebo, Remdesivir)
Recruiting
- Covid19
- Favipiravir
- +2 more
-
Kathmandu, Bagmati, Nepal
- +1 more
Jan 3, 2021
COVID-19 Trial in Minas Gerais, Bangkok, Samut Prakan (Favipiravir, Monoclonal antibodies, Ivermectin)
Recruiting
- COVID-19
- Favipiravir
- +4 more
-
Minas Gerais, Brazil
- +3 more
Feb 4, 2022